Vetsys Pharmaceutical
Vetsys Pharmaceutical
Ethiopia holds the largest livestock population in Africa, with over 60 million cattle, 30 million sheep, and 30 million goats. As the backbone of the Ethiopian economy, the health and productivity of this sector are paramount. In recent years, the demand for high-quality Injectable Suspensions has surged across regions like Oromia, Amhara, and Tigray, as commercial dairy farming and intensive beef production become more formalized.
As a premier supplier and factory partner, we recognize that Ethiopia's unique climate—ranging from the cool highlands to the arid Rift Valley—requires robust pharmaceutical formulations. Injectable suspensions, particularly those containing long-acting antibiotics like Penicillin and Amoxicillin, are essential for treating respiratory infections, mastitis, and tick-borne diseases common in the Horn of Africa.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our state-of-the-art facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, injectable suspensions, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in strict compliance with Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015. We are now expanding our footprint in Ethiopia to support the local agricultural transformation.
We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands in Ethiopia and produce cutting-edge solutions for animal health.
Quality is our cornerstone. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market.
Vetsys is committed to green technologies. Our future strategy for Ethiopia includes partnerships, research collaborations, and expanding manufacturing capabilities to meet the increasing demand for safe animal drugs.
In the Ethiopian context, the application of injectable suspensions is highly specialized. Our products are designed for several key scenarios:
Our manufacturing process utilizes the latest automation to ensure particle size consistency in our suspensions, preventing syringe blockage and ensuring rapid absorption. From the selection of raw materials to the final packaging, every step is monitored by AI-driven quality control systems.
Mold Injection
Welding
Assembly
Packaging
Injection Molding
Blow Molding
Extrusion Molding
Cotton Swab Processing
Drying
Assembly
PackingThe industry is shifting towards Import Substitution. The Ethiopian government's "Homegrown Economic Reform" agenda encourages local pharmaceutical production. Vetsys is aligning with this by exploring knowledge transfer and local distribution hubs. We are also seeing a rise in Herbal Drug Extracts as complementary therapies to traditional antibiotics, an area where Vetsys holds significant expertise with our independent research institute.
Our vision is to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare in Ethiopia and beyond.
Partner with a factory that understands the African pharmaceutical market. Get specialized pricing and distribution support today.
